Biohaven Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

239

Market Cap

3.67B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BHVN News

4 days ago - Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval - Benzinga
5 days ago - Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates - PRNewsWire
15 days ago - Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting - PRNewsWire
23 days ago - Biohaven's Revenue Path: SCA And Obesity Therapies - Seeking Alpha
26 days ago - Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
26 days ago - Biohaven's spinal muscular atrophy drug fails to meet main goal in study - Reuters
26 days ago - Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity - PRNewsWire
5 weeks ago - Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments - PRNewsWire

More News